HCA Healthcare, Inc. $HCA Shares Purchased by Mesirow Financial Investment Management Inc.

Mesirow Financial Investment Management Inc. increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 33.1% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,320 shares of the company’s stock after buying an additional 328 shares during the quarter. Mesirow Financial Investment Management Inc.’s holdings in HCA Healthcare were worth $506,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Cheviot Value Management LLC purchased a new stake in HCA Healthcare in the first quarter valued at $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare in the first quarter valued at $26,000. WPG Advisers LLC purchased a new stake in HCA Healthcare in the first quarter valued at $27,000. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Finally, Chung Wu Investment Group LLC acquired a new position in HCA Healthcare during the 2nd quarter worth $27,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 1.4%

Shares of HCA stock opened at $460.11 on Friday. The company has a market cap of $107.66 billion, a price-to-earnings ratio of 17.79, a price-to-earnings-growth ratio of 1.38 and a beta of 1.40. The stock has a 50 day simple moving average of $421.11 and a 200-day simple moving average of $386.84. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $478.19.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the prior year, the business posted $4.90 EPS. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Wall Street Analyst Weigh In

HCA has been the subject of several analyst reports. Royal Bank Of Canada upped their price objective on HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Raymond James Financial set a $525.00 price objective on HCA Healthcare in a research report on Monday, October 27th. Truist Financial boosted their target price on HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a report on Monday, October 27th. Finally, KeyCorp boosted their target price on HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $473.53.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.